Rowan Companies (RDC) estimates, target lowered at UBS. Shares of RDC now seen reaching $41, according to UBS. Estimates also lowered on higher operating and interest expenses. Buy rating.
Rowan Companies numbers lowered at Jefferies. Shares of RDC now seen reaching $45, Jefferies said. Estimates also lowered on disappointing guidance. Buy rating.
SM Energy (SM) target lowered at Jefferies tO $93, Jefferies said. Plans provide visibility into vast probables value but main challenge is managing cash flows. Buy rating.
Tenet Healthcare (THC) numbers raised at Credit Suisse. Shares of THC now seen reaching $7, according to Credit Suisse. Estimates also increased, as growth should accelerate in the second half of the year. Outperform rating.Tractor Supply (TSCO) numbers increased at BofA/Merrill through 2014, Bank of America/Merrill Lynch said. Demand has been solid and the company is buying back more shares. Buy rating and new $95 price target. ViroPharma Incorporated (VPHM - Get Report) target raised at Oppenheimer to $34, Oppenheimer said. Addition of Buccolam to net present value. Outperform rating. ViroPharma Incorporated numbers raised at Jefferies. Shares of VPHM now seen reaching $37, Jefferies said. Estimates also raised on expanded manufacturing capacity. Buy rating. >To submit a news tip, email: firstname.lastname@example.org.
Follow TheStreet on Twitter and become a fan on Facebook.